Strong client satisfaction Beaufort CRO reports a 94% client satisfaction rate relative to other CROs, signaling high customer advocacy and potential for repeat engagement and referrals in MedTech trials.

Agility as differentiator Emphasize Beaufort’s senior-level engagement, direct decision-maker access, and adaptable strategy as a value proposition for fast-paced regulatory pathways and tight clinical timelines.

Therapeutic breadth With deep experience across cardiovascular, orthopedics, neurology, oncology, women’s health, infectious disease, and digital health, target medtech companies seeking end-to-end regulatory, clinical, and software-enabled trial support.

Regulatory leadership Leverage Beaufort’s track record of 500+ regulatory submissions and expertise in diagnostics, companion diagnostics, and AI-enabled tech to pursue early-phase to late-phase opportunities requiring complex regulatory navigation.

Global reach, lean scale Highlight its 2,600 professionals across 50+ countries and 4,000+ clinical sites to offer scalable deployment for multinational trials, appealing to midsize to larger life sciences partners seeking global trial execution.